top of page
Royalty Programmes
Research Royalty Programme
All sales of enzymes from the literature enzyme collection generate royalty payments for the associated academic group. This is a non-contractual royalty of 5% of sales revenue.
Commercial Academic Partnership (CAP)
This enables the rapid and hassle-free commercialisation of your clones encoding recombinant enzymes and proteins. As your partner in this venture, we will perform and fund all aspects of production, purification, preparation / stabilisation, stocking, marketing, supply and support, and provide you with a generous 17.5% royalty-based payment on all sales.
bottom of page